Latest CHRS News

• Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates - Zacks Investment Research - Thu, May 9, 2024 9:15 PM
• Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire Inc. - Thu, May 9, 2024 8:01 PM
• Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates - Zacks Investment Research - Wed, May 8, 2024 12:25 PM
• Coherus to Report First Quarter 2024 Financial Results on May 9, 2024 - GlobeNewswire Inc. - Wed, May 1, 2024 8:30 PM
• Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewswire Inc. - Wed, Apr 24, 2024 2:02 PM
• Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting - GlobeNewswire Inc. - Mon, Apr 8, 2024 12:30 PM
• Why Coherus Biosciences Stock Tumbled on Thursday - The Motley Fool - Thu, Mar 14, 2024 10:28 PM
• Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update - GlobeNewswire Inc. - Wed, Mar 13, 2024 8:01 PM
• Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024 - GlobeNewswire Inc. - Tue, Mar 5, 2024 9:01 PM
• Coherus Completes Divestiture of Ophthalmology Franchise - GlobeNewswire Inc. - Mon, Mar 4, 2024 6:00 AM